Aveanna Healthcare Holdings, Inc.
AVAHdata completeness 88%7 fiscal years on fileAveanna Healthcare Holdings, Inc. earns about -1% on invested capital, but has diluted owners by 125895% over 5 years — worth asking whether the growth reaches owners. The cash-flow models don't apply cleanly here — the ledger says why below.Whether it’s worth owning at today’s price is the last question — and yours to answer, below.
| Figure | FY 2022 | FY 2022 | FY 2023 | FY 2024 | FY 2026 |
|---|---|---|---|---|---|
| Revenue | $1.68B1 | $1.79B2 | $1.9B3 | $2.02B4 | $2.43B4 |
| Net income | −$117M5 | −$662M6 | −$134.5M7 | −$10.9M8 | $225M8 |
| Operating cash flow | −$11.4M9 | −$48.4M10 | $22.7M11 | $32.6M12 | $125.9M12 |
| Capital expenditure | $16M13 | — | — | — | — |
| Free cash flow (derived) | −$27.3M9 | — | — | — | — |
| Total debt | $2.47B14 | $2.58B15 | $2.57B16 | $2.56B17 | $2.6B17 |
| Cash & equivalents | $30.5M18 | $19.2M19 | $43.9M20 | $84.3M21 | $193.3M21 |
| Diluted shares | 170,625 | 185.6M | 190.0M | 192.9M | 215.0M |
Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).
10 shares is a claim on $9.05 of net worth that earned you $10.47 last year, against $120.93 of debt.
It earned an average -1% on invested capital over 5 years. Compare that to what it costs to fund the business.
seeing a moat in the numbers →Share count is up 125895% over 5 years — owners have been diluted. Worth asking what they got for it. Total debt has held roughly steady.
reading capital allocation →Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.
assumptions (1)
- grahamMultiplier2250.0%
Different models answer different questions — which to trust when →
- 10-K · period ending 2022-01-01 · accession 0000950170-23-008309 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2022-12-31 · accession 0000950170-24-031321 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2023-12-30 · accession 0000950170-25-038504 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2024-12-28 · accession 0001193125-26-115851 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2022-01-01 · accession 0000950170-23-008309 (NetIncomeLoss)
- 10-K · period ending 2022-12-31 · accession 0000950170-24-031321 (NetIncomeLoss)
- 10-K · period ending 2023-12-30 · accession 0000950170-25-038504 (NetIncomeLoss)
- 10-K · period ending 2024-12-28 · accession 0001193125-26-115851 (NetIncomeLoss)
- 10-K · period ending 2022-01-01 · accession 0000950170-23-008309 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2022-12-31 · accession 0000950170-24-031321 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2023-12-30 · accession 0000950170-25-038504 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2024-12-28 · accession 0001193125-26-115851 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2022-01-01 · accession 0000950170-22-004799 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2022-01-01 · accession 0000950170-23-008309 (LongTermDebtNoncurrent)
- 10-K · period ending 2022-12-31 · accession 0000950170-24-031321 (LongTermDebtNoncurrent)
- 10-K · period ending 2023-12-30 · accession 0000950170-25-038504 (LongTermDebtNoncurrent)
- 10-K · period ending 2024-12-28 · accession 0001193125-26-115851 (LongTermDebtNoncurrent)
- 10-K · period ending 2022-01-01 · accession 0000950170-23-008309 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2022-12-31 · accession 0000950170-24-031321 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2023-12-30 · accession 0000950170-25-038504 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2024-12-28 · accession 0001193125-26-115851 (CashAndCashEquivalentsAtCarryingValue)